Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Guilherme S. Ramos"'
Autor:
Frédéric Frézard, Marta M. G. Aguiar, Lucas A. M. Ferreira, Guilherme S. Ramos, Thais T. Santos, Gabriel S. M. Borges, Virgínia M. R. Vallejos, Helane L. O. De Morais
Publikováno v:
Pharmaceutics, Vol 15, Iss 1, p 99 (2022)
The liposomal amphotericin B (AmB) formulation, AmBisome®, still represents the best therapeutic option for cutaneous and visceral leishmaniasis. However, its clinical efficacy depends on the patient’s immunological status, the clinical manifestat
Externí odkaz:
https://doaj.org/article/821d450cbc634ade8b1f7492d52770ff
Autor:
Juliane S. Lanza, Virginia M. R. Vallejos, Guilherme S. Ramos, Ana Carolina B. de Oliveira, Cynthia Demicheli, Luis Rivas, Sébastien Pomel, Philippe M. Loiseau, Frédéric Frézard
Publikováno v:
Pharmaceutics, Vol 14, Iss 8, p 1743 (2022)
This work aims to evaluate whether nanoassemblies (NanoSb) made from antimony(V) complexes with octanoyl-N-methylglucamide (SbL8) or decanoyl-N-methylglucamide (SbL10) would effectively target the infection sites in visceral and cutaneous leishmanias
Externí odkaz:
https://doaj.org/article/8e62a4658a024c4a921dceb6b4c0fade
Autor:
Guilherme S. Ramos, Virgínia M. R. Vallejos, Gabriel S. M. Borges, Raquel M. Almeida, Izabela M. Alves, Marta M. G. Aguiar, Christian Fernandes, Pedro P. G. Guimarães, Ricardo T. Fujiwara, Philippe M. Loiseau, Lucas A. M. Ferreira, Frédéric Frézard
Publikováno v:
Pharmaceutics, Vol 14, Iss 5, p 989 (2022)
Liposomal amphotericin B (AmB) or AmBisome® is the most effective and safe therapeutic agent for visceral leishmaniasis (VL), but its clinical efficacy is limited in cutaneous leishmaniasis (CL) and HIV/VL co-infection. The aim of this work was to d
Externí odkaz:
https://doaj.org/article/21924717897c46609603ca3cfbced1c3